Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Double-blind, Active-controlled, Parallel-group, Randomized, Multi-center Study to Compare Efficacy and Safety of LBSA0103 Once Versus Hyruan Plus Injection Once Weekly for 3weeks in the Treatment of Patients With Osteoarthritis of the Knee

NCT01510535 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT01510535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01510535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Double-blind, Active-controlled, Parallel-group, Randomized, Multi-center Study to Compare Efficacy and Safety of LBSA0103 Once Versus Hyruan Plus Injection Once Weekly for 3weeks in the Treatment of Patients With Osteoarthritis of the Knee
Lead sponsor
LG Life Sciences
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
October 31, 2012
Enrollment
287 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee